TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Cooperative Group Chairman Objects “Personal” Comments, Other Deficiencies In Peer Review January 16, 1981
TCL Archive Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT. April 21, 2000